Mostrar el registro sencillo del ítem

dc.contributor.authorLlop, Sabrina
dc.contributor.authorMurcia, Mario
dc.contributor.authorÁlvarez Pedrerol, Mar
dc.contributor.authorGrimalt, Joan O.
dc.contributor.authorSANTA MARINA, LORETO
dc.contributor.authorJulvez, Jordi
dc.contributor.authorGoñi-Irigoyen, Fernando
dc.contributor.authorEspada, Mercedes
dc.contributor.authorBallester, Ferran
dc.contributor.authorRebagliato, Marisa
dc.contributor.authorLópez Espinosa, María José
dc.date.accessioned2017-10-02T09:35:27Z
dc.date.available2017-10-02T09:35:27Z
dc.date.issued2017-04-08
dc.identifier.citationLLOP, Sabrina; MURCIA, Mario; ÁLVAREZ-PEDREROL, Mar; GRIMALT, Joan O.; SANTA-MARINA RODRÍGUEZ, Loreto; JÚLVEZ, Jordi; GOÑI-IRIGOYEN, Fernando; ESPADA, Mercedes; BALLESTER, Ferran; REBAGLIATO, Marisa; LÓPEZ ESPINOSA, María José. Association between exposure to organochlorine compounds and maternal thyroid status: Role of the iodothyronine deiodinase 1 gene. Environment International (2017), v. 104, p. 83-90ca_CA
dc.identifier.urihttp://hdl.handle.net/10234/169106
dc.description.abstractIntroduction: Exposure to organochlorine compounds (OCs) may interfere with thyroid hormone (TH) homeostasis. The disruption of the deiodinase (DIO) enzymes has been proposed as a mechanism of action. Aim: To evaluate the association between exposure to OCs and TH status in pregnant women, as well as to explore the role of genetic variations in the DIO1 and DIO2 genes. Methods: The study population (n = 1128) was composed of pregnant women who participated in the INMA Project (Spain, 2003–2006). Hexachlorobenzene (HCB), 1,1-dichloro-2,2-bis(4-chlorophenyl)ethylene (4,4´-DDE), b-hexachlorocyclohexane (b-HCH), polychlorobiphenyl (PCB) congeners 138, 153 and 180, thyroid stimulating hormone (TSH), total triiodothyronine (TT3) and free thyroxine (FT4) were measured in serum samples taken during the first trimester of pregnancy (mean [standard deviation (SD)]: 13.5 [2] weeks of gestation). Polymorphisms in DIO1 (rs2235544) and DIO2 (rs12885300) were genotyped in maternal DNA. Sociodemographic and dietary characteristics were obtained by questionnaire. Results: A 2-fold increase in HCB was associated with lower TT3 (% change = − 1.48; 95%CI: − 2.36, − 0.60). Women in the third tertile for b-HCH had lower TT3 (% change = − 3.19; 95%CI: − 5.64, − 0.67). The interactions between DIO1 rs2235544 and PCB153 and b-HCH were statistically significant. The inverse association between PCB153 and TT3 was the strongest among women with AA genotype. Women with CC genotype presented the strongest inverse association between b-HCH and FT4. Conclusion: Exposure to HCB and b-HCH was associated to a disruption in maternal TT3. The DIO1 rs2235544 SNP modified the association between exposure to some of the OCs (specifically b-HCH and PCB153) and maternal thyroid hormone levels. These results strengthen the hypothesis that DIO enzymes play a role in explaining the disruption of thyroid hormones in relation to exposure to OCs. Abbreviations 4,4′-DDE1,1-dichloro-2,2-bis(4-chlorophenyl)ethylene b-HCHb-hexachlorocyclohexane DIOdeiodinase FT4free thyroxine HCBHexachlorobenzene LODlimit of detection OCsorganochlorine compounds PCBspolychlorobiphenyls TBGthyroxine-binding globulin THthyroid hormones TSHthyroid stimulating hormone TTRtransthyretin TT3total triiodothyronineca_CA
dc.format.extent8 p.ca_CA
dc.format.mimetypeapplication/pdfca_CA
dc.language.isoengca_CA
dc.publisherElsevierca_CA
dc.relation.isPartOfEnvironment International (2017), v. 104ca_CA
dc.rights.urihttp://rightsstatements.org/vocab/CNE/1.0/*
dc.subjectPregnancyca_CA
dc.subjectThyroidca_CA
dc.subjectOrganochlorine compoundsca_CA
dc.subjectDeiodinase enzymesca_CA
dc.subjectFetal developmentca_CA
dc.titleAssociation between exposure to organochlorine compounds and maternal thyroid status: Role of the iodothyronine deiodinase 1 geneca_CA
dc.typeinfo:eu-repo/semantics/articleca_CA
dc.identifier.doihttps://doi.org/10.1016/j.envint.2016.12.013
dc.relation.projectIDThis work was supported by grants from the Instituto de Salud Carlos III [Red INMA G03/176 and CB06/02/0041]; the Spanish Ministry of Health [FIS-FEDER 03/1615, 04/1509, 04/1112, 04/1931, 04/1436, 04/2018, 05/1079, 05/1052, 06/1213, 07/0314, 08/1151, 09/02647, 09/2311, 11/01007, 11/02591, 11/02038, 13/1944, 13/2032, 13/2429, 14/00891, 14/01687, and 16/1288] and Miguel Servet-FEDER [CP11/0178, MS14/00108, and MS15/0025]; the Conselleria de Sanitat; Generalitat Valenciana; Generalitat de Catalunya-CIRIT [1999SGR 00241]; Department of Health of the Basque Government [2005111093 and 2009111069]; Department of Education of the Basque Government (BFI-2010_160) pre-doctoral fellowship; the Provincial Government of Gipuzkoa [DFG06/004 and DFG08/001]; FISABIO [UGP-15-230].ca_CA
dc.rights.accessRightsinfo:eu-repo/semantics/restrictedAccessca_CA
dc.relation.publisherVersionhttp://www.sciencedirect.com/science/article/pii/S0160412016303646?via%3Dihubca_CA
dc.date.embargoEndDate2019-04-07
dc.type.versioninfo:eu-repo/semantics/publishedVersionca_CA


Ficheros en el ítem

FicherosTamañoFormatoVer

No hay ficheros asociados a este ítem.

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem